Clinical Utility of Semistructured Interview and Scales to Assess Withdrawal Syndromes With Dose Reduction or Discontinuation of Selective Serotonin Reuptake Inhibitors or Serotonin Norepinephrine Reuptake Inhibitors

BACKGROUND: Withdrawal syndromes can occur after dose reduction or discontinuation of selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs). Few measurement instruments are available to assess them: Diagnostic Clinical Interview for Drug Withdrawal 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Cosci, Fiammetta, Romanazzo, Sara, Mansueto, Giovanni, Rontani, Petra, Levitan, Michelle N., Halkjœr-Lassen, Roseane D., Quagliato, Laiana A., Nakamura, Tomoyuki, Uematsu, Ken, Nardi, Antonio E., Oe, Misari, Chouinard, Virginie-Anne, Chouinard, Guy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907690/
https://www.ncbi.nlm.nih.gov/pubmed/34928557
http://dx.doi.org/10.1097/JCP.0000000000001491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907690/
https://www.ncbi.nlm.nih.gov/pubmed/34928557
http://dx.doi.org/10.1097/JCP.0000000000001491

Ejemplares similares